Molecular Robotics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The molecular robotics market is segmented by Product Type (Software and Consumables, and Devices), Application (Drug Discovery, Genetic Research, and Others), End-User (Research Laboratories, and Pharma and Biotech Companies), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Market Snapshot

molecular robotics market
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: Asia-Pacific
Largest Market: North America
CAGR: 18 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The molecular robotics market is expected to grow at a projected CAGR of 18% over the forecast period, 2022-2027.

After the outbreak of covid-19, all markets were negatively affected due to supply chain disruptions. However, research and development has increased to find potential treatments for covid-19 infection. And the demand for research and development of molecular robotics has increased because it can provide and enable fast and smart treatment options by changing molecules. Many research studies have been conducted to find better patient care and treatment options. In an article published in August 2021, entitled “Robotic RNA extraction for SARS-CoV-2 surveillance using saliva samples” it is mentioned that researchers have developed a robotic nucleic acid extraction method for high-throughput detection of SARS-CoV-2 RNA in saliva samples. More research and studies have also been done to find any cure for Covid-19. These researches and studies have created a demand for molecular robots and have had a positive impact on the market under review.

As the Wyss Institute states, robots and DNA share a similar ability to be programmed to complete a specific function, despite their physical appearance or form. DNA can be programmed with its nucleotide sequences and robots with binary numbers. The source also said that these programmable biological molecules, such as DNA, have unlimited potential for creating nanoscale devices and systems that could be transformative in various industries and fields. These advances make molecular robotics particularly useful in genetic research and drug discovery studies.

The high prevalence of chronic diseases such as cancer and other rare diseases calls attention to new research and studies to be conducted to witness the technological advancement and application of molecular robotics in the field of drug discovery. Key facts updated by the World Health Organization (WHO) in February 2022 show that cancer has become the leading cause of death worldwide, and in 2020 almost 10 million deaths were caused by cancer, or about one in six deaths. Also, the number of breast cancer cases (2.26 million) surpassed the total number of lung cancer cases (2.21) in 2020, according to the above source. This rising incidence of cancer calls for more advanced technology. As molecular robots can read, edit, and alter DNA and RNA, which can create new structures to find a cure for cancer-like disease, the demand for these molecular robots is increasing, which is expected to lead to the growth of the market under forecast period.

As research and development has been on the rise lately, laboratory automation is getting a requirement to maintain a smooth workflow. Molecular robots are designed using advanced technologies to minimize the pressure of learning new software and other equipment, helping scientists increase the overall efficiency of their laboratory and accelerate next-generation research. This is expected to gain demand and gain growth in the studied market during the forecast period.

However, the high cost of development and designing of these molecular robots is expected to restrain the growth of the market over the studied forecast period.

Scope of the Report

As per the scope of the report, molecular robots are designed and capitalized using advanced technologies, to automate scientific workflow easily while minimizing the hassle of learning new software, and equipment. These molecular robots are also suited for a wide variety of research fields including synthetic biology, drug discovery, and biotechnology.

The molecular robotics market is segmented by Product Type (Software and Consumables, and Devices), Application (Drug Discovery, Genetic Research, and Others), End-User (Research Laboratories, and Pharma and Biotech Companies), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product Type
Software and Consumables
By Application
Drug Discovery
Genetic Research
By End-User
Research Laboratories
Pharma and Biotech Companies
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East and Africa
South Africa
Rest of Middle East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Drug Discovery by Application Segment is Expected to Witness a Healthy Growth Over the Forecast Period

The rapid progress of molecular nanotechnology has opened the door to advanced technologies such as molecular robotics. Molecular robotics uses molecules as parts of robots. Drug discovery has gained demand due to the increasing incidence of chronic and rare diseases. Because drug discovery takes time, researchers are now focusing on using molecules as robots and introducing molecular robotics into the drug discovery platform.

Molecular robots can perform basic tasks including building other molecules. Each robot consists of just 150 atoms of carbon, hydrogen, oxygen and nitrogen and can manipulate a single molecule. Researchers at the Massachusetts Institute of Technology (MIT) have created a deep learning model, GeoMol, that can predict the 3D shape of a molecule independently from a 2D graph of its molecular structure, and this GeoMol can help pharmaceutical companies speed up the drug discovery process by narrowing down the number of molecules they need to test in laboratory experiments, as mentioned in the article “How technology can speed up the search for new medicines” published in December 2021.

Springer Nature's Molecular Robotics section updated in February 2021 reports that advances in DNA nanotechnology are increasing the demand for molecular robots made of biomolecules. The source mentioned above also says that these molecular robots can carry drugs with sophisticated information processing capabilities and can also be used for theranostics (a term used for therapy and diagnosis). This growing R&D in drug discovery and the application of molecular robotics in drug discovery is increasing the demand for molecular robots, which is expected to boost the growth of the studied market in this segment.

The increasing number of experiments, clinical trials and fundraisers in the field of drug discovery for the application of biomolecular robots is currently increasing and collecting the growth of the studied market. For example, Owkin, a French AI startup working with its biopharma partners to identify high-risk patients who might respond best to an experimental drug, raised a total of USD 70 million in funding in June 2020 as part of a long-term Series A funding round.

Therefore, the increasing activities by the research organizations and the major market players are driving the growth of the drug discovery segment. This is expected to contribute to the studied market growth over the forecast period.

New Cases of Cancer, Worldwide, 2020

North America is Expected to Dominate the Market Over the Forecast Period

North America is expected to dominate the molecular robotics market and the studied market is expected to grow in the region due to advanced robotics technologies and increased research and developments in the pharmaceutical sector.

The prevalence of chronic diseases, such as cancer and other rare diseases, has recently been increasing in North America. In North America, especially in the United States, research and studies are leaning toward finding better and more advanced drug and treatment options.

Cancer remained the second leading cause of death in the United States after heart disease. In 2022, a total of 1.9 million new cancer cases and 609,360 cancer deaths are expected in the United States, which is about 1,670 deaths per day, according to data released by the American Cancer Society in January 2022. Cancer cases motivate research institutes in the United States to collaborate with research institutes in other North American countries. This collaboration is involved in finding the best cure for this disease. Molecular robots have been found to be one of the most studied cancer drug discovery research in the region.

The presence of a high concentration of market players in the North American region and new product launches by these players are also driving the growth of the researched market in the region. Active participation of universities in drug research and molecular robotics is also supporting the growth of the studied market. For example, Harvard University's Wyss Institute for Biologically Inspired Engineering, along with the University of Vermont and Tufts University, announced in November 2021 that a team of researchers known to have built the first living robot, the Xenobot, had discovered an entirely new form of biological reproduction of this living robot, and that promises numerous opportunities for regenerative medicine development.The advanced research and developments in the region are anticipated to garner the growth of the studied market over the forecast period.

Molecular Robotics Market- Growth Rate By Region

Competitive Landscape

The molecular robotics market is moderately competitive. Some of the companies which are currently dominating the market are Danaher Corporation (Medical Devices, LLC.), Bruker, Thermo Fisher Scientific, Qiagen, Klocke Nanotechnik GmbH, PerkinElmer Inc., Zymergen Inc., International Business Machines Corporation (IBM), Beckman Coulter, Inc., Hudson Robotics, Entos, Inc., Imina Technologies SA, Nanorobotics Ltd., Labplan among others.

Recent Development

  • In April 2022, Scientists at Hokkaido University demonstrated light-manipulated micro-size molecular machines, or robots, that performed cargo delivery through a swarming strategy to ultimately achieve a transport efficiency 5 times greater than that of single robots. The cargo used in the team’s experiments consisted of polystyrene beads laying the application for light-activated microbot swarms to be used in various fields including drug delivery.
  • In January 2022, Frost & Sullivan recognized Insilico Medicine with the 2021 Entrepreneurial Company of the Year Award in the global AI-enabled drug discovery industry.

Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing R&D Investment and Advancements in Robotics Technology

      2. 4.2.2 Increased Use in Drug Development for Rare Diseases

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Moecular Robots Designing and Production

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - in USD Million)

    1. 5.1 By Product Type

      1. 5.1.1 Software and Consumables

      2. 5.1.2 Devices

    2. 5.2 By Application

      1. 5.2.1 Drug Discovery

      2. 5.2.2 Genetic Research

      3. 5.2.3 Others

    3. 5.3 By End-User

      1. 5.3.1 Research Laboratories

      2. 5.3.2 Pharma and Biotech Companies

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Bruker

      2. 6.1.2 Danaher Corporation (Medical Devices, LLC.)

      3. 6.1.3 Entos, Inc.

      4. 6.1.4 Hudson Robotics

      5. 6.1.5 Imina Technologies SA

      6. 6.1.6 International Business Machines Corporation (IBM)

      7. 6.1.7 Klocke Nanotechnik GmbH

      8. 6.1.8 Labplan

      9. 6.1.9 Nanorobotics Ltd.

      10. 6.1.10 PerkinElmer Inc.

      11. 6.1.11 Qiagen

      12. 6.1.12 Thermo Fisher Scientific

      13. 6.1.13 Zymergen Inc.

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Molecular Robotics Market market is studied from 2019 - 2027.

The Global Molecular Robotics Market is growing at a CAGR of 18% over the next 5 years.

Asia-Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Bruker, Danaher Corporation (Medical Devices, LLC.), PerkinElmer, Qiagen, Thermo Fisher Scientific are the major companies operating in Global Molecular Robotics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!